PD-L1 |
BMS-202 |
Serendipity |
NMR, DSF, crystal |
32 |
REV1 |
JH-RE-06 |
Serendipity |
Crystal, SDS-PAGE |
40 |
MDMX |
RO-2443, RO-5986 |
Serendipity |
NMR, SEC-SLS, crystal, TR-FRET |
46 |
BCL6 |
BI-3802 |
Serendipity |
IF, Cryo-EM, WB, TR-FRET |
53 |
CCT369260 |
Serendipity |
Nano-BRET, IF, MSD |
54 |
MERS-CoV |
P3 |
Virtual screening |
SAXS, IF, crystal, thermostability |
61 |
DDB1CRBN–substrate |
Thalidomide, lenalidomide, pomalidomide |
Serendipity |
Proteomic, LC‒MS/MS, crystal, TR-FRET |
62,63
|
CC-122, CC-220 |
Rational design |
Crystal, WB, TR-FRET |
64,65
|
CC-885 |
Rational design |
IP, crystal, pull-down, IF, LC‒MS/MS, SPPIER |
67 |
CC-90009 |
Rational design |
WB, proteomic, crystal |
69 |
SJ6986 |
Rational design |
WB, MD simulation |
68 |
DDB1DCAF15–RBM39 |
Indisulam, E7820 |
Serendipity |
IP, LC‒MS/MS, CRISPR/Cas9, pull-down, Cryo-EM, TR-FRET |
77,78
|
DDB1–CDK12/cyclinK |
dCeMM2, dCeMM3, dCeMM4 |
Chemical screening |
WB, CRISPR/Cas9, pull-down |
83 |
(R)-CR8 |
Data mining |
Co-IP, ITC, crystal, TR-FRET, nano-BRET |
85 |
HQ461 |
HTS |
CRISPR/Cas9, Co-IP, WB, pull-down, CXMS, LC‒MS/MS, DSF, thermostability |
84 |
SCFβ-TrCP–β-catenin |
NRX-252114, NRX-252262, NRX-103094 |
HTS, rational design |
FP, crystal, TR-FRET, pull-down |
89 |
LC3-mHTT |
10O5, 8F20, AN1, AN2 |
HTS |
SMM, OI-RD, HTRF, MST, pull-down, IF |
93 |
GLP-1–GLP-1R |
LSN3160440 |
HTS, rational design |
Crystal, MD simulation, IF |
101 |